APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).
about
Transnasal delivery of human A-beta peptides elicits impaired learning and memory performance in wild type mice.Effects of specific multi-nutrient enriched diets on cerebral metabolism, cognition and neuropathology in AβPPswe-PS1dE9 miceGalantamine slows down plaque formation and behavioral decline in the 5XFAD mouse model of Alzheimer's disease.Longitudinal analysis of the behavioral phenotype in a novel transgenic rat model of early stages of Alzheimer's disease.A longitudinal study of cognition, proton MR spectroscopy and synaptic and neuronal pathology in aging wild-type and AβPPswe-PS1dE9 miceHuman neural stem cells alleviate Alzheimer-like pathology in a mouse model.Hypertension, cerebrovascular impairment, and cognitive decline in aged AβPP/PS1 miceKnock-in of human BACE1 cleaves murine APP and reiterates Alzheimer-like phenotypesA brief overview of amyloids and Alzheimer's disease.Genetic Deletion of the Clathrin Adaptor GGA3 Reduces Anxiety and Alters GABAergic Transmission.Neurologic and motor dysfunctions in APP transgenic mice.Non-alcoholic fatty liver disease induces signs of Alzheimer's disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD modelAn update of animal models of Alzheimer disease with a reevaluation of plaque depositions.Characterization of altered intrinsic excitability in hippocampal CA1 pyramidal cells of the Aβ-overproducing PDAPP mouse.S14G-humanin alleviates insulin resistance and increases autophagy in neurons of APP/PS1 transgenic mouse.Kalirin reduction rescues psychosis-associated behavioral deficits in APPswe/PSEN1dE9 transgenic mice.Synergistic Effect on Neurodegeneration by N-Truncated Aβ4-42 and Pyroglutamate Aβ3-42 in a Mouse Model of Alzheimer's Disease.
P2860
Q27315991-CBB172D9-30A0-46FE-90C5-9E78251D7B61Q28533783-111F1D01-FB70-4B5E-8519-39478E9FECCCQ28540060-6A49B9A1-6CA4-4F04-907B-24BCFA0DA2D7Q30587067-A790FBB0-F9DB-4172-82D7-5F50CD468101Q30635401-CECFA5F5-8B8B-472B-AC05-0AC7BB817FB6Q30662068-AAC94545-E511-401C-8668-A4F3DFB7CB8AQ33588229-60B302ED-183D-4D17-A9DA-45713803E6AEQ34006919-8775F760-876F-4CDE-B3F0-0535DE0B5482Q34868191-B999001F-28ED-455B-AEDD-E87FE0DC36E4Q36021405-C7EEE094-10FF-4D47-9D77-07A2DA96A10EQ36347389-9A798218-C046-44EC-9A37-128F99AB39E2Q36428502-2B2BCF1B-16C4-445D-A011-06FED394002BQ36976873-F6198AF6-2444-461C-BD9B-E292F107A697Q38789229-51F81B09-4BA0-41F6-9D0C-7835EB6A0570Q47616956-EFFA7053-763C-400B-9969-98832338C452Q47771892-F1B9325C-D1F1-474F-8857-E2B4B68819C2Q51760411-D04C0E25-80EE-4910-BBB0-F2A6771252FA
P2860
APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
APP transgenic mice for modell ...... l symptoms of dementia (BPSD).
@ast
APP transgenic mice for modell ...... l symptoms of dementia (BPSD).
@en
type
label
APP transgenic mice for modell ...... l symptoms of dementia (BPSD).
@ast
APP transgenic mice for modell ...... l symptoms of dementia (BPSD).
@en
prefLabel
APP transgenic mice for modell ...... l symptoms of dementia (BPSD).
@ast
APP transgenic mice for modell ...... l symptoms of dementia (BPSD).
@en
P2093
P2860
P1476
APP transgenic mice for modell ...... l symptoms of dementia (BPSD).
@en
P2093
C Strazielle
P2860
P304
P356
10.1016/J.NEUBIOREV.2012.02.011
P577
2012-02-21T00:00:00Z